Interactive Online Informational and Peer Support App for Patients with Low Anterior Resection Syndrome
1 other identifier
interventional
101
1 country
5
Brief Summary
After surgery for rectal cancer, many people undergo changes in bowel habits, which may include the need to empty their bowels more often, accidental leakage of stool or gas, the sudden urge to go to the bathroom, and more. The term "Low Anterior Resection Syndrome" or LARS is used to describe these symptoms. LARS has a negative impact on one's quality of life, and can lead to frustration, as there is no single intervention that has proven to be effective for LARS, and each patient has to undergo trial and error to find one's solution. As people struggle with LARS, they describe feeling hopeless and isolated. Peer support is a supportive relationship between individuals who share common experiences or face similar challenges. The goal of our study is to evaluate whether use of an online peer support application with trained mentors who themselves have lived or are living with LARS will empower patients to better manage their LARS symptoms and improve their quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2020
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2020
CompletedFirst Posted
Study publicly available on registry
July 14, 2020
CompletedStudy Start
First participant enrolled
August 15, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 12, 2024
CompletedNovember 29, 2024
November 1, 2024
2.2 years
March 23, 2020
November 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
European Organization for Research and Treatment of Cancer - Quality of Life Questionnaire - C30 questionnaire
Questionnaire measures baseline quality of life before app use. Maximum score 100 (better function, quality of life). Minimum score 0 (worse function, quality of life).
1 week before the launch of the app
Assessing 'Change' via European Organization for Research and Treatment of Cancer - Quality of Life Questionnaire - C30 questionnaire after 6 months
Questionnaire measures change in quality of life after app use. Maximum score 100 (better function, quality of life). Minimum score 0 (worse function, quality of life).
6 months after using the app.
Secondary Outcomes (4)
Patient activation measures
1 week before the launch of the app
Change in Patient activation measures
6 months after using the app.
Bowel function Low Anterior Resection Syndrome score
1 week before the launch of the app
Bowel function Low Anterior Resection Syndrome score
6 months after using the app.
Study Arms (2)
Informational online app group
EXPERIMENTALParticipants will have access to an interactive online peer support app developed by the research team.
Booklet only
NO INTERVENTIONParticipants will only have access to the educational booklet on LARS developed by the colorectal research team.
Interventions
The app contains LARS information, bowel function diaries, and online platform with trained peer support mentor
Eligibility Criteria
You may qualify if:
- underwent restorative protectomy for Neo-plastic disease of the rectum
- completed all treatment within the last 3 years
- patients with minor or major LARS as defined with the LARS score.
You may not qualify if:
- Active chemotherapy or radiotherapy
- Major colonic resection in addition to protectomy
- Cannot be contacted by telephone
- Unable to read and comprehend English/French
- Does not have the appropriate interface to access the app
- Unable to give clear and informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jewish General Hospitallead
- Providence Healthcarecollaborator
- Mount Sinai Hospital, Canadacollaborator
- University Health Network, Torontocollaborator
- McGill University Health Centre/Research Institute of the McGill University Health Centrecollaborator
Study Sites (5)
St Paul's Hospital
Vancouver, British Columbia, V6Z 1Y6, Canada
Mount Sinai Hospital
Toronto, Ontario, Canada
University Health Network
Toronto, Ontario, Canada
Jewish General Hospital
Montreal, Quebec, H3T1E2, Canada
McGill University Health Centre
Montreal, Quebec, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 23, 2020
First Posted
July 14, 2020
Study Start
August 15, 2020
Primary Completion
October 31, 2022
Study Completion
November 12, 2024
Last Updated
November 29, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share